Companies /Healthcare

Upstream Bio, Inc.

NASDAQ: UPB Biotechnology
$5.19
▼ $0.12 (−2.17%) today
Markets open · 3:43pm ET

Fundamentals

Market Cap
$290.3M
Revenue (TTM)
$3.2M
EPS (TTM)
$-2.88
52-Week Range
$5 – $34
Street Target
$31.14

About Upstream Bio

Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases that focuses on severe respiratory disorders. The company is headquartered in Waltham, Massachusetts.

UPB Coverage